Studying cytochrome P450 kinetics in drug metabolism
Authors:
- 18 May 2008
- journal article
- review article
- Published by Taylor & Francis in Expert Opinion on Drug Metabolism & Toxicology
- Vol. 4 (5) , 591-603
Abstract
Background: Determination of cytochrome P450 enzyme-mediated kinetics in vitro can be useful for predicting drug dosing and clearance in humans. Expressed P450s, human liver microsomes, human hepatocytes (both fresh and cryopreserved), and human liver slices are used to estimate Km and Vmax values for determination of intrinsic clearance of the drug for scale-up to predict in vivo clearance. Objective: To describe the advantages and disadvantages of the various in vitro systems used to estimate kinetic parameters for disposition of drugs and the various kinetic profiles that can be observed. Methods: A review of the literature was conducted to evaluate the utility of the various in vitro preparations, the methods for determining kinetic parameters and the types of kinetic profiles that may be observed. Results/conclusions: The choice of in vitro system for determining kinetic parameters will depend on the objective of the studies, as each system has advantages and disadvantages. Kinetic parameter determinations must be carefully assessed to assure that the correct kinetic model is applied and the most accurate kinetic parameters are determined.Keywords
This publication has 55 references indexed in Scilit:
- Effect of Commonly Used Organic Solvents on the Kinetics of Cytochrome P450 2B6- and 2C8-Dependent Activity in Human Liver MicrosomesDrug Metabolism and Disposition, 2007
- EXPRESSION AND INDUCTION POTENTIAL OF CYTOCHROMES P450 IN HUMAN CRYOPRESERVED HEPATOCYTESDrug Metabolism and Disposition, 2005
- EVALUATION OF FRESH AND CRYOPRESERVED HEPATOCYTES AS IN VITRO DRUG METABOLISM TOOLS FOR THE PREDICTION OF METABOLIC CLEARANCEDrug Metabolism and Disposition, 2004
- Organ slices for the evaluation of human drug toxicityChemico-Biological Interactions, 2004
- Effect of Age on in Vitro Triazolam Biotransformation in Male Human Liver MicrosomesThe Journal of Pharmacology and Experimental Therapeutics, 2004
- Influence of culture time on the expression of drug‐metabolizing enzymes in primary human hepatocytes and hepatoma cell line HepG2Journal of Biochemical and Molecular Toxicology, 2003
- Inhibition‐Based Metabolic Drug–Drug Interactions: Predictions from In Vitro DataJournal of Pharmaceutical Sciences, 2002
- CYP2D6.10 present in human liver microsomes shows low catalytic activity and thermal stabilityBiochemical and Biophysical Research Communications, 2002
- Roles of Divalent Metal Ions in Oxidations Catalyzed by Recombinant Cytochrome P450 3A4 and Replacement of NADPH-Cytochrome P450 Reductase with Other Flavoproteins, Ferredoxin, and Oxygen SurrogatesBiochemistry, 1995
- The Human Hepatic Cytochromes P450 Involved in Drug MetabolismCritical Reviews in Toxicology, 1992